View in EDS

Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors.

Saved in:
Bibliographic Details
Title: Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors.
Authors: Mfuh AM; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Boerth JA; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Bommakanti G; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Chan C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Chinn AJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Code E; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Fricke PJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Giblin KA; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Gohlke A; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hansel C; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Hariparsad N; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Hughes SJ; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Jin M; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Kantae V; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Kavanagh SL; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Lamb ML; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Lane J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Moore R; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Puri T; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Quinn TR; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Reddy I; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Robb GR; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Robbins KJ; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Gancedo Rodrigo M; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Isomorphic Laboratories, 280 Bishopsgate, London EC2M 4RB, U.K., Schimpl M; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Singh B; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Singh M; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Tang H; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Thomson C; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Walsh JJ; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Ware J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Watson IDG; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Ye MW; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Wrigley GL; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K., Zhang AX; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Zhang Y; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States., Grimster NP; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.
Source: Journal of medicinal chemistry [J Med Chem] 2024 Jan 25; Vol. 67 (2), pp. 1500-1512. Date of Electronic Publication: 2024 Jan 16.
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38227216
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mfuh+AM%22">Mfuh AM</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Boerth+JA%22">Boerth JA</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Bommakanti+G%22">Bommakanti G</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Chan+C%22">Chan C</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Chinn+AJ%22">Chinn AJ</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Code+E%22">Code E</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Fricke+PJ%22">Fricke PJ</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Giblin+KA%22">Giblin KA</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Gohlke+A%22">Gohlke A</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Hansel+C%22">Hansel C</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Hariparsad+N%22">Hariparsad N</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Hughes+SJ%22">Hughes SJ</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Jin+M%22">Jin M</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Kantae+V%22">Kantae V</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Kavanagh+SL%22">Kavanagh SL</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Lamb+ML%22">Lamb ML</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Lane+J%22">Lane J</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Moore+R%22">Moore R</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Puri+T%22">Puri T</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Quinn+TR%22">Quinn TR</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Reddy+I%22">Reddy I</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Robb+GR%22">Robb GR</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Robbins+KJ%22">Robbins KJ</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Gancedo+Rodrigo+M%22">Gancedo Rodrigo M</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.; Isomorphic Laboratories, 280 Bishopsgate, London EC2M 4RB, U.K.<br /><searchLink fieldCode="AU" term="%22Schimpl+M%22">Schimpl M</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Singh+B%22">Singh B</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Singh+M%22">Singh M</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Tang+H%22">Tang H</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Thomson+C%22">Thomson C</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Walsh+JJ%22">Walsh JJ</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Ware+J%22">Ware J</searchLink>; Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Watson+IDG%22">Watson IDG</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Ye+MW%22">Ye MW</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Wrigley+GL%22">Wrigley GL</searchLink>; Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.<br /><searchLink fieldCode="AU" term="%22Zhang+AX%22">Zhang AX</searchLink>; Discovery Sciences, R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.<br /><searchLink fieldCode="AU" term="%22Grimster+NP%22">Grimster NP</searchLink>; Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2024 Jan 25; Vol. 67 (2), pp. 1500-1512. <i>Date of Electronic Publication: </i>2024 Jan 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38227216
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acs.jmedchem.3c02083
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1500
    Titles:
      – TitleFull: Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mfuh AM
      – PersonEntity:
          Name:
            NameFull: Boerth JA
      – PersonEntity:
          Name:
            NameFull: Bommakanti G
      – PersonEntity:
          Name:
            NameFull: Chan C
      – PersonEntity:
          Name:
            NameFull: Chinn AJ
      – PersonEntity:
          Name:
            NameFull: Code E
      – PersonEntity:
          Name:
            NameFull: Fricke PJ
      – PersonEntity:
          Name:
            NameFull: Giblin KA
      – PersonEntity:
          Name:
            NameFull: Gohlke A
      – PersonEntity:
          Name:
            NameFull: Hansel C
      – PersonEntity:
          Name:
            NameFull: Hariparsad N
      – PersonEntity:
          Name:
            NameFull: Hughes SJ
      – PersonEntity:
          Name:
            NameFull: Jin M
      – PersonEntity:
          Name:
            NameFull: Kantae V
      – PersonEntity:
          Name:
            NameFull: Kavanagh SL
      – PersonEntity:
          Name:
            NameFull: Lamb ML
      – PersonEntity:
          Name:
            NameFull: Lane J
      – PersonEntity:
          Name:
            NameFull: Moore R
      – PersonEntity:
          Name:
            NameFull: Puri T
      – PersonEntity:
          Name:
            NameFull: Quinn TR
      – PersonEntity:
          Name:
            NameFull: Reddy I
      – PersonEntity:
          Name:
            NameFull: Robb GR
      – PersonEntity:
          Name:
            NameFull: Robbins KJ
      – PersonEntity:
          Name:
            NameFull: Gancedo Rodrigo M
      – PersonEntity:
          Name:
            NameFull: Schimpl M
      – PersonEntity:
          Name:
            NameFull: Singh B
      – PersonEntity:
          Name:
            NameFull: Singh M
      – PersonEntity:
          Name:
            NameFull: Tang H
      – PersonEntity:
          Name:
            NameFull: Thomson C
      – PersonEntity:
          Name:
            NameFull: Walsh JJ
      – PersonEntity:
          Name:
            NameFull: Ware J
      – PersonEntity:
          Name:
            NameFull: Watson IDG
      – PersonEntity:
          Name:
            NameFull: Ye MW
      – PersonEntity:
          Name:
            NameFull: Wrigley GL
      – PersonEntity:
          Name:
            NameFull: Zhang AX
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Grimster NP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 01
              Text: 2024 Jan 25
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1520-4804
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of medicinal chemistry
              Type: main
ResultId 1